Abstract
The last decade has witnessed the development of a wide variety of diagnostic tests for Chlamydia trachomatis. In order to determine what laboratory methods are being used to detect C. trachomatis infections in Washington State and to identify factors influencing test selection, between April 1995 and October 1995 we conducted a mailed questionnaire survey of all 112 laboratories certified to do chlamydia testing. Of these, 20 had discontinued testing for C. trachomatis, and responses were obtained from 89 (97%) of the remaining 92 laboratories. Surprisingly, 38 (43%) of the 89 laboratories used rapid tests such as Clearview and Surecell, making such tests the most commonly used laboratory tests. Laboratories which used rapid tests had lower test volumes, less experience performing tests for C. trachomatis, less frequent attendance at professional meetings, and greater reliance on manufacturers for information compared with laboratories which used other methods. Confirmation of non-culture-positive results was provided by 28 (34%) of the 82 laboratories doing non-culture-based tests. Forty-one (47%) of 88 laboratories reported having compared their method with another method. Test volume was the strongest predictor of laboratories which confirmed positive non-culture-based test results and which had performed a laboratory comparison of methods. We conclude that rapid tests for C. trachomatis are often being used inappropriately and that efforts are needed to improve effective implementation and quality assurance of laboratory testing for C. trachomatis.
Full Text
The Full Text of this article is available as a PDF (115.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Addiss D. G., Vaughn M. L., Ludka D., Pfister J., Davis J. P. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis. 1993 Jan-Feb;20(1):28–35. doi: 10.1097/00007435-199301000-00006. [DOI] [PubMed] [Google Scholar]
- Biro F. M., Reising S. F., Doughman J. A., Kollar L. M., Rosenthal S. L. A comparison of diagnostic methods in adolescent girls with and without symptoms of Chlamydia urogenital infection. Pediatrics. 1994 Mar;93(3):476–480. [PubMed] [Google Scholar]
- Chan E. L., Brandt K., Horsman G. B. A 1-year evaluation of Syva MicroTrak Chlamydia enzyme immunoassay with selective confirmation by direct fluorescent-antibody assay in a high-volume laboratory. J Clin Microbiol. 1994 Sep;32(9):2208–2211. doi: 10.1128/jcm.32.9.2208-2211.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hook E. W., 3rd, Spitters C., Reichart C. A., Neumann T. M., Quinn T. C. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA. 1994 Sep 21;272(11):867–870. [PubMed] [Google Scholar]
- Kellogg J. A., Seiple J. W., Stroll E. S. Direct fluorescent-antibody confirmation of chlamydial antigen below the detection threshold of the chlamydiazyme enzyme-linked immunosorbent assay. J Clin Microbiol. 1993 Jun;31(6):1646–1647. doi: 10.1128/jcm.31.6.1646-1647.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kluytmans J. A., Goessens W. H., Mouton J. W., van Rijsoort-Vos J. H., Niesters H. G., Quint W. G., Habbema L., Stolz E., Wagenvoort J. H. Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol. 1993 Dec;31(12):3204–3210. doi: 10.1128/jcm.31.12.3204-3210.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCormack W. M., Alpert S., McComb D. E., Nichols R. L., Semine D. Z., Zinner S. H. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med. 1979 Jan 18;300(3):123–125. doi: 10.1056/NEJM197901183000305. [DOI] [PubMed] [Google Scholar]
- Schachter J., Stamm W. E., Chernesky M. A., Hook E. W., 3rd, Jones R. B., Judson F. N., Kellogg J. A., LeBar B., Mårdh P. A., McCormack W. M. Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis. 1992 Sep-Oct;19(5):243–244. [PubMed] [Google Scholar]
- Scholes D., Stergachis A., Heidrich F. E., Andrilla H., Holmes K. K., Stamm W. E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23;334(21):1362–1366. doi: 10.1056/NEJM199605233342103. [DOI] [PubMed] [Google Scholar]
- Schwebke J. R., Stamm W. E., Handsfield H. H. Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women. J Clin Microbiol. 1990 Nov;28(11):2473–2476. doi: 10.1128/jcm.28.11.2473-2476.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sellors J. W., Mahony J. B., Chernesky M. A., Rath D. J. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis. Fertil Steril. 1988 Mar;49(3):451–457. doi: 10.1016/s0015-0282(16)59772-6. [DOI] [PubMed] [Google Scholar]
- Svensson L., Mårdh P. A., Ahlgren M., Nordenskjöld F. Ectopic pregnancy and antibodies to Chlamydia trachomatis. Fertil Steril. 1985 Sep;44(3):313–317. [PubMed] [Google Scholar]
- Washington A. E., Johnson R. E., Sanders L. L., Jr Chlamydia trachomatis infections in the United States. What are they costing us? JAMA. 1987 Apr 17;257(15):2070–2072. [PubMed] [Google Scholar]